...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Share transfer RBC
1
May 01, 2019 10:56PM
1
May 02, 2019 08:21AM
2
May 02, 2019 10:40AM
2
May 02, 2019 04:23PM

May 03, 2019 07:49AM

Koo

I agree with you 100%

I have been pushing for Zenith to put forth a proper market value for common shares for years and have spoken to various board members with no success.

If Zenith meets or exceeds my expectations, having shares sheltered is my number one goal.

 

GLTA dyodd

2
May 03, 2019 10:17AM
1
May 03, 2019 11:50AM
2
May 03, 2019 01:33PM
Share
New Message
Please login to post a reply